Leave a comment

What you always wanted to know about overseas internationalization at BIO-Europe

The bioXclusters alliance aims to support the internationalization of European SMEs and to act as a single entry point to Europe for international healthcare players. To support this process, bioXclusters has built a network of “Gateways,” which enables win-win collaborations between European life sciences clusters and overseas markets.

In order to present new Gateway organizations, which facilitate SME softlanding in global key markets, bioXclusters organizes a session at BIO-Europe 2017 in Berlin, Germany: “Global Gateways for European life science clusters and their companies. This year´s BIO-Europe partnering event is expected to attract Continue reading

Advertisements
Images from European Biotech and Pharma Partnering Conference in Osaka, Japan 2016


Leave a comment

bioXclusters reinforces its pathways to the Japanese market

Japan is the second largest pharmaceutical market in the world and leader in imports of the sector. Japanese life sciences companies are in the process of globalization and need alliances with foreign companies and biotechnology institutions to develop new medicines and incorporate new technologies. To that end, Japan is a strategic market for bioXclusters metacluster alliance. In collaboration with its Japanese Gateway Osaka Bio Headquarters, and with support of the EU-Japan Centre for industrial collaboration, bioXclusters organizes a mission to Japan in October 2017, following the 2016 success.

The organized mission allows to attend the following events. 

  • BioJapan (11-13 October 2017): Asia-wide benchmark trade fair for the global biotechnology industry that will bring together key business development and licensing professionals, R&D professionals and executives from biotechnology companies. This year’s fair also includes a HealthCare management and digital health area.

Aforementioned European Biotech and Pharma Partnering Conference in Osaka offers business contacts to industry professionals who are looking for Continue reading

South Australian Health and Medical Research Instititue (SAHMRI) in Adelaide


Leave a comment

What Adelaide, Australia has to offer to Medical Device Companies; A Webinar by Marco Baccanti

bioXclusters plus is organizing several activities with their gateways in order to ease SME landing in our target markets. In this case, we are organizing a webinar to understand the Adelaide life sciences ecosystem (Australia) and to get to know the benefits offered to medical devices companies. The seminar will feature Marco Baccanti, Chief Executive of Health Industries South Australia and is open to all companies in the bioXclusters plus area. Continue reading

BioFM Executive Board members and bioXclusters plus partners sign the China Gateway


Leave a comment

bioXclusters plus SMEs will benefit from a Chinese Gateway through Fenglin Group

This Monday, May 15th, representatives from bioXclusters plus and Fenglin Group signed a Gateway Agreement to offer free services and guidance for SMEs in their operations in China. Services will include assistance in market access, private investment, clinical trials and soft landing packages.  Continue reading


Leave a comment

bioXclusters plus paves the way for precision medicine companies to China Market

On 15th – 16th May bioXclusters plus will carry out a China Mission, bringing clusters and companies together at the Sino European Bio Partnering (SEBP) event at a reduced rate. Following bioXclusters plus strategy, the metacluster alliance will sign an MoU with Fenglin Group in order to provide guidance, consultancy and support to European life -sciences SMEs interested in doing business in China. Continue reading


Leave a comment

Focusing on international expansion to Canada and America in healthcare at BIOEurope Spring

Canada is a country presenting interesting assets for European companies undergoing international expansion, as expressed by the SME members of the bioXclusters+ regions, Auvergne-Rhône-Alps (Lyonbiopole), Bavaria (BioM), Catalonia (Biocat) and  Piedmont (bioPmed).

In order to build up collaboration opportunities, the bioXclusters+ alliance, the European Strategic Cluster Partnership on Personalised Healthcare – co-funded by the COSME Programme of the European Union -, has started discussions with some cluster organisations during BIO Intl. Convention in San Francisco in June 2016. Among them, TOHealth!, an industry-led public private partnership, working as the Toronto Cluster organisation, shares our strong interest to foster external relations and our a strong focus in Personalized Healthcare. Apart from this, a mutual collaboration MoU has been signed between TOHealth! (link) and bioXclusters plus in December 2016 for building bioXclusters+ gateways in Canada.

To that end, bioXclusters+ is organizing a session within BIO-Europe Spring 2017 to compare business environments for the Continue reading


Leave a comment

A new MoU signed with South Korea – Chuncheon Bioindustry Foundation

The bioXclusters plus alliance is pleased to announce that in November 2016, it signed a new, two-year cooperation agreement with the Chuncheon Bioindustry Foundation (CBF) from South Korea. CBF is a government funded organisation, which contributes to the improvement of local and national bioindustries.

CBF provides several systematic supports for biotech business. It represents member companies and research organisations located in the Gangwon Province of South Korea which work in the fields of biotechnology, pharmacy and medical science .

For more information about CBF, please visit the CBF website by clicking here.